TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas

Life Sciences

Volumn 122, Issue , 2015, Pages 37-41

  Hong, Seokchan ^a   Kim, Eun Jin ^a   Lee, Eun Ju ^a   Koo, Bon San ^a,b   Ahn, Soo Min ^a   Bae, Seung Hyeon ^a   Lim, Doo Ho ^a   Kim, Yong Gil ^a   Yoo, Bin ^a   Lee, Chang Keun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Apoptosis; Fas; Fas ligand; Rheumatoid arthritis

Indexed keywords

AUTACOID; FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA; FAS PROTEIN, HUMAN; FASLG PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNITY; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; PATHOLOGY;

ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELL MEMBRANE; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; HUMANS; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919936219     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.12.008     Document Type: Article

References (32)

1. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, N.S. Cooper, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum. 31 (1988) 315-324.
2. A. Ates, G. Kinikli, M. Turgay, M. Duman, The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis, Clin. Rheumatol. 23 (2004) 421-425.
3. J.P. Aubry, A. Blaecke, S. Lecoanet-Henchoz, P. Jeannin, N. Herbault, G. Caron, et al., Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity, Cytometry 37 (1999) 197-204.
4. N. Bottini, G.S. Firestein, Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors, Nat. Rev. Rheumatol. 9 (2013) 24-33.
5. J.R. Bradley, TNF-mediated inflammatory disease, J. Pathol. 214 (2008) 149-160.
6. I. Cascino, G. Fiucci, G. Papoff, G. Ruberti, Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing, J. Immunol. 154 (1995) 2706-2713.
7. J. Cheng, T. Zhou, C. Liu, J.P. Shapiro, M.J. Brauer, M.C. Kiefer, et al., Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule, Science 263 (1994) 1759-1762.
8. H. Hashimoto, M. Tanaka, T. Suda, T. Tomita, K. Hayashida, E. Takeuchi, et al., Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis, Arthritis Rheum. 41 (1998) 657-662.
9. T. Hasunuma, N. Kayagaki, H. Asahara, S. Motokawa, T. Kobata, H. Yagita, et al., Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis, Arthritis Rheum. 40 (1997) 80-86.
10. S. Hayashi, Y.Miura, T. Nishiyama, M. Mitani, K. Tateishi, Y. Sakai, et al., Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis, Arthritis Rheum. 56 (2007) 1067-1075.
11. T. Kobayashi, K. Okamoto, T. Kobata, T. Hasunuma, T. Sumida, K. Nishioka, Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells, Arthritis Rheum. 42 (1999) 519-526.
12. T. Kobayashi, K. Okamoto, T. Kobata, T. Hasunuma, T. Kato, H. Hamada, et al., Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules, Arthritis Rheum. 43 (2000) 1106-1114.
13. A. Korb, H. Pavenstadt, T. Pap, Cell death in rheumatoid arthritis, Apoptosis 14 (2009) 447-454.
14. H. Liu, R.M. Pope, Apoptosis in rheumatoid arthritis: friend or foe, Rheum. Dis. Clin. N. Am. 30 (2004) 603-625 x.
15. H. Liu, P. Eksarko, V. Temkin, G.K. Haines 3rd, H. Perlman, A.E. Koch, et al., Mcl-1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis, J. Immunol. 175 (2005) 8337-8345.
16. I.B. McInnes, G. Schett, The pathogenesis of rheumatoid arthritis, N. Engl. J.Med. 365 (2011) 2205-2219.
17. I. Meinecke, A. Cinski, A. Baier, M.A. Peters, B. Dankbar, A. Wille, et al., Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5073-5078.
18. T. Nakajima, H. Aono, T. Hasunuma, K. Yamamoto, T. Shirai, K. Hirohata, et al., Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes, Arthritis Rheum. 38 (1995) 485-491.
19. C.A. Notley, J.J. Inglis, S. Alzabin, F.E. McCann, K.E. McNamee, R.O.Williams, Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells, J. Exp. Med. 205 (2008) 2491-2497.
20. L.A. O'Reilly, L. Tai, L. Lee, E.A. Kruse, S. Grabow,W.D. Fairlie, et al., Membrane-bound Fas ligand only is essential for Fas-induced apoptosis, Nature 461 (2009) 659-663.
21. S. Ohshima, T. Mima, M. Sasai, K. Nishioka, M. Shimizu, N. Murata, et al., Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possiblemechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA, Cytokine 12 (2000) 281-288.
22. G. Palao, B. Santiago, M. Galindo, M. Paya, J.C. Ramirez, J.L. Pablos, Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis, Arthritis Rheum. 50 (2004) 2803-2810.
23. S.L. Peng, Fas (CD95)-related apoptosis and rheumatoid arthritis, Rheumatology (Oxford). 45 (2006) 26-30.
24. H. Perlman, C. Georganas, L.J. Pagliari, A.E. Koch, K. Haines 3rd, R.M. Pope, Bcl-2 expression in synovial fibroblasts is essential for maintaining mitochondrial homeostasis and cell viability, J. Immunol. 164 (2000) 5227-5235.
25. H. Perlman, L.J. Pagliari, H. Liu, A.E. Koch, G.K. Haines 3rd, R.M. Pope, Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis, Arthritis Rheum. 44 (2001) 21-30.
26. R.M. Pope, Apoptosis as a therapeutic tool in rheumatoid arthritis, Nat. Rev. Immunol. 2 (2002) 527-535.
27. E. Romano, R. Terenzi, M. Manetti, F. Peruzzi, G. Fiori, F. Nacci, et al., Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors correlates with increased soluble Fas levels, J. Rheumatol. 41 (2014) 1961-1965.
28. E. Romano, M. Manetti, F. Peruzzi, D. Melchiorre, A.F. Milia, S. Bellando-Randone, et al., Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications, Haemophilia 20 (2014) e32-e39.
29. D.L. Scott, F. Wolfe, T.W. Huizinga, Rheumatoid arthritis, Lancet 376 (2010) 1094-1108.
30. M. Sugiyama, T. Tsukazaki, A. Yonekura, S. Matsuzaki, S. Yamashita, K. Iwasaki, Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis, Ann. Rheum. Dis. 55 (1996) 442-449.
31. I. Vermes, C. Haanen, H. Steffens-Nakken, C. Reutelingsperger, A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V, J. Immunol. Methods 184 (1995) 39-51.
32. H.G. Zhang, N. Huang, D. Liu, L. Bilbao, X. Zhang, P. Yang, et al., Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts, Arthritis Rheum. 43 (2000) 1094-1105.